{
    "accessibility": "Open access",
    "additionDate": "2019-08-09T13:14:40Z",
    "bioagentsCURIE": "bioagents:TPES",
    "bioagentsID": "TPES",
    "cost": "Free of charge",
    "credit": [
        {
            "email": "alessio.locallo@gmail.com",
            "name": "Alessio Locallo",
            "typeEntity": "Person",
            "typeRole": [
                "Primary contact"
            ]
        },
        {
            "email": "f.demichelis@unitn.it",
            "name": "Francesca Demichelis",
            "typeEntity": "Person",
            "typeRole": [
                "Primary contact"
            ]
        }
    ],
    "description": "Tumor Purity Estimation from SNVs.",
    "documentation": [
        {
            "type": [
                "User manual"
            ],
            "url": "https://bitbucket.org/l0ka/tpes/src/master/TPES-manual.pdf"
        }
    ],
    "download": [
        {
            "type": "Source code",
            "url": "https://bitbucket.org/l0ka/tpes/src/master/TPES_1.0.0.tar.gz"
        }
    ],
    "editPermission": {
        "type": "private"
    },
    "homepage": "https://bitbucket.org/l0ka/tpes.git",
    "language": [
        "R"
    ],
    "lastUpdate": "2020-06-16T10:55:26Z",
    "license": "MIT",
    "maturity": "Mature",
    "name": "TPES",
    "operatingSystem": [
        "Linux",
        "Mac",
        "Windows"
    ],
    "owner": "hans",
    "publication": [
        {
            "doi": "10.1093/BIOINFORMATICS/BTZ406",
            "metadata": {
                "abstract": "Â© 2019 The Author(s) 2019. Published by Oxford University Press. All rights reserved.Motivation: Tumor purity (TP) is the proportion of cancer cells in a tumor sample. TP impacts on the accurate assessment of molecular and genomics features as assayed with NGS approaches. State-of-the-art agents mainly rely on somatic copy-number alterations (SCNA) to quantify TP and therefore fail when a tumor genome is nearly euploid, i.e. 'non-aberrant' in terms of identifiable SCNAs. Results: We introduce a computational method, tumor purity estimation from single-nucleotide variants (SNVs), which derives TP from the allelic fraction distribution of SNVs. On more than 7800 whole-exome sequencing data of TCGA tumor samples, it showed high concordance with a range of TP agents (Spearman's correlation between 0.68 and 0.82; >9 SNVs) and rescued TP estimates of 1, 194 samples (15%) pan-cancer. Availability and implementation: TPES is available as an R package on CRAN and at https://bitbucket.org/l0ka/tpes.git. Supplementary information: Supplementary data are available at Bioinformatics online.",
                "authors": [
                    {
                        "name": "Demichelis F."
                    },
                    {
                        "name": "Fedrizzi T."
                    },
                    {
                        "name": "Locallo A."
                    },
                    {
                        "name": "Prandi D."
                    }
                ],
                "citationCount": 5,
                "date": "2019-11-01T00:00:00Z",
                "journal": "Bioinformatics",
                "title": "TPES: Tumor purity estimation from SNVs"
            },
            "pmid": "31099386",
            "type": [
                "Primary"
            ]
        }
    ],
    "agentType": [
        "Library"
    ],
    "topic": [
        {
            "term": "Genetic variation",
            "uri": "http://edamontology.org/topic_0199"
        },
        {
            "term": "Sequencing",
            "uri": "http://edamontology.org/topic_3168"
        }
    ],
    "validated": 1
}
